Schips Luigi, Dalpiaz Orietta, Cestari Andrea, Lipsky Katja, Gidaro Stefano, Zigeuner Richard, Petritsch Peter
Department of Urology, Medical University Graz, Austria.
Eur Urol. 2006 Oct;50(4):801-5. doi: 10.1016/j.eururo.2006.03.010. Epub 2006 Apr 24.
Haemostasis remains the greatest challenge during laparoscopic partial nephrectomy. Use of fibrin sealant currently is increasing. We describe first a technique for achieving effective haemostasis during laparoscopic partial nephrectomy using the Vivostat system.
Ten patients underwent laparoscopic partial nephrectomy. Autologous fibrin sealant was prepared with the Vivostat system and applied to the resection bed. This system is an automated medical device for the preparation of an autologous fibrin sealant, generating up to 5 ml of sealant from 120 ml of the patient's blood. The concentration of fibrin and the volume of sealant are stable; the sealant may be kept at room temperature for up to 8 hours before application without a loss of properties and effectiveness. The patients were evaluated for acute and delayed bleeding.
Mean patient's age was 54 years (range, 31-68). Haemostasis was immediate in all cases after application of the sealant for 1 to 2 minutes to the resection site; no additional haemostatic measures were required. Mean warm ischemia time was 23 minutes (range, 20-27); mean blood loss was 90 cc (range, 20-200). Pre-operative and post-operative serum haemoglobin did not differ significantly (mean, 14.9 vs 12.6g/dl) and creatinine values (mean, 0.91 vs 0.95 ng/ml). Mean operative time was 136 minutes (range, 60-180). No postoperative bleeding or other complications occurred.
In this study, immediate haemostasis was achieved and maintained after the kidney was reperfused. Our initial experience with the Vivostat system in laparoscopic partial nephrectomy has been encouraging.
止血仍是腹腔镜部分肾切除术面临的最大挑战。目前纤维蛋白密封剂的使用正在增加。我们首次描述了一种使用Vivostat系统在腹腔镜部分肾切除术中实现有效止血的技术。
10例患者接受了腹腔镜部分肾切除术。使用Vivostat系统制备自体纤维蛋白密封剂,并应用于切除床。该系统是一种用于制备自体纤维蛋白密封剂的自动化医疗设备,可从120毫升患者血液中生成多达5毫升密封剂。纤维蛋白浓度和密封剂体积稳定;密封剂在应用前可在室温下保存长达8小时,而不会损失性能和有效性。对患者进行急性和延迟出血评估。
患者平均年龄为54岁(范围31 - 68岁)。在切除部位应用密封剂1至2分钟后,所有病例均立即止血;无需额外的止血措施。平均热缺血时间为23分钟(范围20 - 27分钟);平均失血量为90毫升(范围20 - 200毫升)。术前和术后血清血红蛋白无显著差异(平均值分别为14.9和12.6克/分升),肌酐值也无显著差异(平均值分别为0.91和0.95纳克/毫升)。平均手术时间为136分钟(范围60 - 180分钟)。未发生术后出血或其他并发症。
在本研究中,肾脏再灌注后立即实现并维持了止血。我们在腹腔镜部分肾切除术中使用Vivostat系统的初步经验令人鼓舞。